30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital
HeFRA
Extensive Post-discharge Counselling and Phone-based Follow-up Intervention to Reduce Heart Failure Readmission- A Pilot Randomized Control Trial
1 other identifier
interventional
220
1 country
1
Brief Summary
In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2025
CompletedStudy Start
First participant enrolled
July 14, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
September 10, 2026
August 1, 2026
2.5 years
July 1, 2025
September 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the occurrence of heart failure-related hospital readmission within 30 days and within 90 days after discharge from the index hospitalization
the occurrence of heart failure-related hospital readmission within 30 days and within 90 days after discharge from the index hospitalization
90 days
Secondary Outcomes (4)
1. Readmission rate of heart failure patients on guideline-directed heart failure medications
90days
Quality of life of the heart failure patients at 90 days
90days
All-cause mortality within 30 and 90 days
90 days
Caregiver burden in heart failure management
30 days
Study Arms (2)
control/Usual Care
NO INTERVENTIONThe usual care (counselling by their attending physicians and their normal outpatient reviews).
intervention arm
EXPERIMENTALInterventions
Counselling by their attending physicians plus Extensive post-discharge counselling from a study doctor/pharmacist/a trained nurse and telephone follow-ups in addition to their normal outpatient reviews. The telephone follow-ups will be weekly for the first 30 days and then 4 weekly till day 90.
Eligibility Criteria
You may qualify if:
- · Adults Aged 18 years and above
- Diagnosed with heart failure
- NYHA Class II-IV
- Informed consent
You may not qualify if:
- · NHYA class I
- Patients who do not have access to a mobile phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Komfo Anokye Teaching Hospital
Kumasi, Ashanti Region, Ghana
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2025
First Posted
August 3, 2025
Study Start
July 14, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
September 10, 2026
Record last verified: 2026-08